Acute and Sustained Release of the Atrial Natriuretic Factor Prohormone N-Terminus with Acute Myocardial Infarction
- 31 March 1991
- journal article
- Published by Elsevier BV in The American Journal of the Medical Sciences
- Vol. 301 (3), 157-164
- https://doi.org/10.1097/00000441-199103000-00002
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Increased Release of the N-Terminal and C-Terminal Portions of the Prohormone of Atrial Natriuretic Factor During Immersion-Induced Central Hypervolemia in Normal HumansExperimental Biology and Medicine, 1989
- Prohormone atrial natriuretic peptides 1-30 and 31-67 increase in hyperthyroidism and decrease in hypothyroidismThe American Journal of the Medical Sciences, 1989
- Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency.Heart, 1988
- Secretion of N-terminal fragment of gamma-human atrial natriuretic polypeptide.Hypertension, 1988
- Two new hormones: Prohormone atrial natriuretic peptides 1–30 and 31–67 circulate in manBiochemical and Biophysical Research Communications, 1988
- Circadian Rhythm of Prohormone Atrial Natriuretic Peptides 1-30, 31-67 and 99-126 in ManChronobiology International, 1988
- Atrial natriuretic prohormone peptides 1–30, 31–67, and 79–98 vasodilate the aortaBiochemical and Biophysical Research Communications, 1987
- Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility.Hypertension, 1984
- Bioactive Cardiac Substances: Potent Vasorelaxant Activity in Mammalian AtriaScience, 1983
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981